http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AR-082973-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6572ff5df928fd17340eb2a8cb6d8502
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D419-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D271-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D291-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-554
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-55
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D515-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-554
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-553
filingDate 2011-09-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_05d683b00c4245ca5b53ff95268d1964
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ec67aac371c5c9e2bce2f6912a91498f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9821fc94da341369f1d1ed477dcbdc6e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bb63e32b4f7cc62ca7d8f599b80d6fc8
publicationDate 2013-01-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber AR-082973-A1
titleOfInvention DERIVATIVES OF DIHIDROBENZOXATIAZEPINAS, ITS PREPARATION PROCEDURE AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
abstract Claim 1: Compounds of formula (1) wherein R 1 represents a hydrogen atom, a cyano group, linear or branched C 1-6 alkoxycarbonyl, linear or branched C 1-6 alkylsulfonylaminoalkyl, a N-hydroxycarboximidamide group, or a heterocyclic group, its enantiomers and diastereoisomers, as well as its addition salts with a pharmaceutically acceptable acid or base, it being understood that the term heterocyclic group designates a monocyclic aromatic group of 5 links, which contains one to four heteroatoms, identical or different, chosen from nitrogen, oxygen and sulfur, said heterocyclic group may be optionally substituted with one or more substituents, identical or different, chosen from linear or branched C1-6 alkyl or linear or branched C1-6 polyhaloalkyl.
priorityDate 2010-09-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID402
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419556970
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID977
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454973655
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID947
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458392451
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419523291
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559526

Total number of triples: 38.